Sign In

News Story

ACS CAN reacts to resignation of FDA Commissioner Scott Gottlieb

The former venture capitalist and Hodgkin's lymphoma survivor says he is leaving his post after less than two years to spend more time with his wife and three daughters in CT

The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN), responding to the news that Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, 46, will be stepping down from his position in one month:

“As head of the FDA, Commissioner Gottlieb successfully elevated the burden of tobacco use, particularly among youth, as an urgent issue of national importance with deadly consequences. On behalf of those impacted by cancer, we appreciate Commissioner Gottlieb’s intent to lower nicotine levels and prohibit menthol flavoring in cigarettes, along with a commitment to restrict the sale of other flavored tobacco products, including cigars and e-cigarettes. If fully implemented, those key measures would significantly improve the health of our nation and reduce cancer death. These proposals must move forward despite the commissioner’s departure.

“At a time when youth use of tobacco products has been labeled as an epidemic by leaders in the public health community, Commissioner Gottlieb’s successor must rise above any political pressures and do what is best for the health our nation and our children as we continue to work to end the scourge of tobacco use in this country."

Read The Washington Post story about Commissioner Gottlieb's resignation.




back to top